Page last updated: 2024-09-04

xylose and Leukemia, Myeloid

xylose has been researched along with Leukemia, Myeloid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blijlevens, NM; de Pauw, BE; Donnelly, JP; M'Rabet, L; van't Land, B	1
Bow, EJ; Gallant, G; Rubinger, M; Schacter, BA; Shore, TB; Williams, GJ; Woloschuk, D	1

Trials

1 trial(s) available for xylose and Leukemia, Myeloid

Article	Year
Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Cancer, 1998, Oct-01, Volume: 83, Issue:7 Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Idarubicin; Intestinal Mucosa; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Xylose	1998

Article

Year

Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.

Cancer, 1998, Oct-01, Volume: 83, Issue:7

Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Idarubicin; Intestinal Mucosa; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Xylose

1998

Other Studies

1 other study(ies) available for xylose and Leukemia, Myeloid

Article	Year
Measuring mucosal damage induced by cytotoxic therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:4 Topics: 3-O-Methylglucose; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Leukemia, Myeloid; Male; Middle Aged; Mouth Mucosa; Myelodysplastic Syndromes; Permeability; Rhamnose; Stomatitis; Transplantation Conditioning; Whole-Body Irradiation; Xylose	2004

Article

Year

Measuring mucosal damage induced by cytotoxic therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:4

Topics: 3-O-Methylglucose; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Leukemia, Myeloid; Male; Middle Aged; Mouth Mucosa; Myelodysplastic Syndromes; Permeability; Rhamnose; Stomatitis; Transplantation Conditioning; Whole-Body Irradiation; Xylose

2004